References
- Tatemoto K. Neuropeptide Y: Complete amino acid sequence of the brain peptide. Proc Natl Acad Sci 1982; 70: 5485–9
- de Quidt M E, Emson P C. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system – II. Immunohistochemical analysis. Neuroscience 1986; 18: 545–618
- Adrian T E, Allen J M, Bloom S R, Ghatei M A, Rossor M N, Roberts G W, Crow T J, Tatemoto K, Polak J M. Neuropeptide Y distribution in human brain. Nature 1983; 306: 584–6
- Everitt B J, Hokfelt T, Terenius L, Tatemoto K, Mutt V, Goldstein M. Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience 1984; 11: 443–62
- Sundler F, Håkanson R, Ekblad E, Uddman R, Wahlestedt C. Neuropeptide in peripheral adrenergic and enteric nervous system. Ann Rev Cytol 1986; 102: 234–69
- Hendry S HC, Jones E G, de Felipe J, Schmechel D, Brandon C, Emson P C. Neuropeptide-containing neurons of the cerebral cortex are also GABA-ergic. Proc Natl Acad Sci 1984; 81: 6526–30
- Albers H E, Ferris C F, Se Leeman, Goldman B D. Avian pancreatic polypeptide phase shifts hamster circadian rhythms when microinjected into the suprachiasmatic region. Science 1983; 223: 883–5
- Levine A S, Morley J E. Neuropeptide Y: A potent inducer of consumatory behavior in rats. Peptides 1984; 5: 1025–9
- Wahlestedt C, Skagerberg G, Ekman R, Heilig M, Sundler F, Håkanson R. Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Res 1987; 417: 33–8
- Schildkraut J J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 1965; 122: 509–22
- Siever U, Davis K L. Overview: Towards a dysregulation hypothesis of depression. Am J Psychiatry 1985; 122: 1017–31
- Lundberg J M, Hökfelt T. Multide co-existence of peptides and classical transmitters in peripheral autonomic and sensory neurons – functional and pharmacological implications. Progress in Brain Research, T. Hökfelt, K. Fuxe, B. Pernow. Elsevier. 1986; 68: 241–62
- Wahlestedt C, Ekman R, Håkanson R, Heilig M, Sundler F, Widerlöv E. Is neuropeptide Y involved in the pathogenesis of major depression? – Relationship to monoamine turnover and corticotropin-releasing factor. Soc Neursci Abstr 1986; 12: 1243
- American Psychiatric Association. Diagnostic and statistical manual of mental disordersThird Ed. APA, Washington, DC 1980, (DSM-III)
- Montgomery S A, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382–9
- Hamilton M. Development of rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278–96
- Cairncross K D. Olfactory bulbectomy as a model of depression. Animal models in psychopathology. Academic Press. 1984; 99
- Ekman R, Wahlestedt C, Böttcher G, Håkanson R, Panula P. Peptide YY-like immunoreactivity in the central nervous system of the rat. Regul Pept 1986; 16: 157–68
- Widerlöv E. The future of neuropeptides in psychiatry and neurology. Neuropeptides in Psychiatric and Neurological Disease. Johns Hopkins University Press. 1987; 281–306
- Ekman R, Widerlöv E, Walléus H, Lindström L H. Elevated levels of NPY-like material in CSF in depression. ISPNE-XVth International Congress. Vienna July, 1984; 73
- Zini I, Pinch M, Fuxe K, Lenzi P L, Agnati L F, Härfstrand A, Mutt V, Tatemoto K, Moscara M. Actions of centrally administered neuropeptide Y on EEG activity in different rat strains and in different phases of their circadian cycle. Acta Physiol Scand 1984; 122: 71–7